EPS Diluted (TTM) Chart

Historical EPS Diluted (TTM) Data

View and export this data back to 1997. Start Trial.
Date Value
September 30, 2026 7.732
June 30, 2026 7.238
March 31, 2026 6.540
December 31, 2025 6.949
September 30, 2025 6.624
June 30, 2025 6.440
March 31, 2025 6.404
December 31, 2024 5.369
September 30, 2024 5.219
June 30, 2024 3.473
March 31, 2024 2.292
December 31, 2023 2.564
September 30, 2023 0.5704
June 30, 2023 1.022
March 31, 2023 1.744
December 31, 2022 -4.652
September 30, 2022 -3.979
June 30, 2022 -3.444
March 31, 2022 -3.550
December 31, 2021 1.913
September 30, 2021 3.871
June 30, 2021 2.069
March 31, 2021 3.905
December 31, 2020 4.690
September 30, 2020 3.307
Date Value
June 30, 2020 -12.46
March 31, 2020 -14.04
December 31, 2019 -14.24
September 30, 2019 -14.06
June 30, 2019 4.51
March 31, 2019 0.1033
December 31, 2018 -0.0767
September 30, 2018 2.32
June 30, 2018 0.74
March 31, 2018 5.36
December 31, 2017 5.75
September 30, 2017 3.44
June 30, 2017 4.04
March 31, 2017 4.20
December 31, 2016 4.17
September 30, 2016 4.13
June 30, 2016 4.327
March 31, 2016 4.193
December 31, 2015 4.113
September 30, 2015 3.998
June 30, 2015 3.621
March 31, 2015 3.415
December 31, 2014 3.235
September 30, 2014 3.17
June 30, 2014 3.38

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Cencora, Inc. 17.91
McKesson Corp. 38.88
CVS Health Corp. 8.603
Amgen, Inc. 17.24
Henry Schein, Inc. 3.655